Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Neurovision Receives Financing for Retinal Imaging Technology

Facebook Twitter LinkedIn Email Comments
Imaging and diagnostic solutions provider Neurovision Imaging LLC has raised financing for regulatory approval of its retinal imaging technology for the early detection and monitoring of Alzheimer’s-related amyloid pathology.

The company’s imaging technology focuses on the retina, a developmental outgrowth of the central nervous system sharing many of the brain's characteristics, enabling the potential of retinal imaging for amyloid detection in Alzheimer's disease.

The Series B financing was led by a $5 million investment from Wildcat Capital Management. A portion of the funds is being reserved for strategic investors.

Leonard Potter, chief investment officer and president of Wildcat Capital Management, has been named to Neurovision’s board of directors.

Sep 2016
1. The photosensitive membrane on the inside of the human eye. 2. A scanning mechanism in optical character generation.
BusinessAmericasCalifornianeurovisionBiophotonicsAlzheimer’simagingretinawildcatfundingdiagnosticspeopleleonard potterRapidScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.